Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women's Health
February 27, 2024 08:35 ET
|
Biom Pharmaceutical Corporation
Sarasota, Florida, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Biom Pharmaceutical, a microbiome biotech company, announced today the publication of the results of the clinical study on VagiBiom®...